Spots Global Cancer Trial Database for active surveillance
Every month we try and update this database with for active surveillance cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Active Surveillance for Low Risk Prostate Cancer | NCT04146077 | Prostate Cancer Prostate Adenoc... | 50 Years - 75 Years | I.M. Sechenov First Moscow State Medical University | ||
Comparison of Surgery and Active Surveillance in the Treatment of Bosniak III Renal Cysts | NCT04670887 | Cystic Renal Di... Kidney Cancer Surgery | Delayed surgery Immediate surge... | 50 Years - 75 Years | Helsinki University Central Hospital | |
Active Surveillance Exercise Clinical Trial | NCT02435472 | Localized Prost... Active Surveill... | Exercise Cardiopulmonary... | 18 Years - | University of California, San Francisco | |
STHLM3 AS NorDCaP - a Followup Study of Men on Active Surveillance of Prostate Cancer | NCT04627948 | Prostate Cancer | Stockholm3 test | 40 Years - 75 Years | Karolinska Institutet | |
SPCG17: Prostate Cancer Active Surveillance Trigger Trial | NCT02914873 | Prostate Cancer | Active surveill... | - | Uppsala University | |
Evaluation of an Active Surveillance Protocol for Prostate Cancer in the Brazilian Population | NCT05343936 | Prostate Cancer | Active surveill... | 18 Years - 78 Years | Hospital Moinhos de Vento | |
Long-Term Prospective Registry in Prostate Cancer Patients From Diverse Urology Practice Settings Following Prolaris® Testing | NCT04404894 | Prostate Cancer | 18 Years - | Myriad Genetic Laboratories, Inc. | ||
Postoperative Adjuvant Sintilimab in Hepatocellular Carcinoma With Microvascular Invasion | NCT06089369 | Hepatocellular ... | Sintilimab (9 c... Sintilimab (18 ... Active surveill... | 18 Years - 75 Years | Tongji Hospital | |
Nevoid Basal Cell Carcinomas in Gorlin Syndrome | NCT05898347 | Basal Cell Carc... Gorlin Syndrome | Active surveill... | 6 Years - 17 Years | Oslo University Hospital | |
Active Surveillance for Low-risk Papillary Thyroid Carcinoma | NCT06261190 | Thyroid Cancer Papillary Thyro... | 18 Years - | National Cancer Center, Korea | ||
Active Surveillance Magnetic Resonance Imaging Study | NCT01354171 | Prostate Cancer | MRI assisted TR... | 18 Years - | Canadian Urology Research Consortium | |
Active Surveillance for Prostate Cancer With Indolent Features | NCT00421265 | Prostate Cancer | 65 Years - 80 Years | Assaf-Harofeh Medical Center | ||
Active Surveillance for Low-risk Papillary Thyroid Carcinoma | NCT06261190 | Thyroid Cancer Papillary Thyro... | 18 Years - | National Cancer Center, Korea | ||
Prognostic Factors in Prostate Cancer for Patients Treated by Watchful Waiting | NCT03912883 | Prostate Cancer | 18 Years - 76 Years | Queen Mary University of London | ||
Active Surveillance and Surgery Outcomes in Low Risk Papillary Thyroid Cancer | NCT04624477 | Papillary Thyro... Papillary Thyro... Papillary Micro... | 18 Years - | University Health Network, Toronto | ||
Red Yeast Rice in Subjects With Clinically Localized Prostate Cancer Undergoing Active Surveillance | NCT01687049 | Prostate Cancer | Red yeast rice | 19 Years - 90 Years | Sunnybrook Health Sciences Centre | |
Deciding on Active Surveillance or Surgery for Primary Management of Low Risk Papillary Thyroid Cancer | NCT03271892 | Thyroid Cancer ... | 18 Years - 100 Years | University Health Network, Toronto | ||
Active Surveillance for Low-risk Prostate Cancer - Evaluation of the Efficacy of Minimally Invasive Active Surveillance | NCT03956108 | Prostate Cancer | MRI+targeted bi... PSA + systemati... | 45 Years - | Karolinska Institutet | |
Feasibility Study on a Nordic Lifestyle Intervention Trial Among Men With Prostate Cancer | NCT01300104 | Prostate Cancer | Exercise Whole grain rye Recommendations | 55 Years - 70 Years | Danish Cancer Society | |
A Trial Comparing USG-HIFU vs AS in Management of Low-risk PTMC | NCT03327636 | Papillary Thyro... | Echopulse | 19 Years - 74 Years | The University of Hong Kong | |
Protocol Active Surveillance Small Renal Masses (SRMs) | NCT03804320 | Kidney Cancer | Active Surveill... | 50 Years - | IRCCS San Raffaele | |
Early Detection of Breast Cancer and Cervical Cancer in Women in India | NCT00632047 | Breast Cancer Cervical Cancer | active surveill... educational int... examination long-term scree... | 35 Years - 64 Years | National Cancer Institute (NCI) | |
Deciding on Active Surveillance or Surgery for Primary Management of Low Risk Papillary Thyroid Cancer | NCT03271892 | Thyroid Cancer ... | 18 Years - 100 Years | University Health Network, Toronto | ||
Active Surveillance Exercise Clinical Trial | NCT02435472 | Localized Prost... Active Surveill... | Exercise Cardiopulmonary... | 18 Years - | University of California, San Francisco | |
STHLM3 AS NorDCaP - a Followup Study of Men on Active Surveillance of Prostate Cancer | NCT04627948 | Prostate Cancer | Stockholm3 test | 40 Years - 75 Years | Karolinska Institutet | |
Docetaxel Compared With Observation in Treating Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer | NCT00376792 | Prostate Cancer | docetaxel active surveill... adjuvant therap... | 18 Years - 70 Years | National Cancer Institute (NCI) | |
CAPSAICIN Trial: Assessing Capsaicin as a Chemopreventive Agent for Prostate Cancer | NCT02037464 | Prostate Cancer | Capsaicin Suppl... | 19 Years - | Sunnybrook Health Sciences Centre | |
Prognostic Factors in Prostate Cancer for Patients Treated by Watchful Waiting | NCT03912883 | Prostate Cancer | 18 Years - 76 Years | Queen Mary University of London | ||
Feasibility Study on a Nordic Lifestyle Intervention Trial Among Men With Prostate Cancer | NCT01300104 | Prostate Cancer | Exercise Whole grain rye Recommendations | 55 Years - 70 Years | Danish Cancer Society | |
Green Tea Extract in Treating Patients With Low-Risk Prostate Cancer | NCT01928485 | Stage I Prostat... Stage IIA Prost... Stage IIB Prost... | active surveill... Sunphenon laboratory biom... Questionnaire A... | 45 Years - 85 Years | Case Comprehensive Cancer Center | |
Using Walk With Ease Walking Program With Men 65 and Older Being Treated for Prostate Cancer | NCT02139774 | Prostate Cancer | Walk with Ease | 65 Years - | UNC Lineberger Comprehensive Cancer Center | |
Survivorship Care Planning in Improving Quality of Life in Survivors of Ovarian Cancer | NCT02082470 | Cancer Survivor Stage IA Ovaria... Stage IB Ovaria... Stage IC Ovaria... Stage IIA Ovari... Stage IIB Ovari... Stage IIC Ovari... Stage IIIA Ovar... Stage IIIB Ovar... Stage IIIC Ovar... | follow-up care active surveill... questionnaire a... | 21 Years - | City of Hope Medical Center | |
Active Surveillance on Papillary Thyroid Microcarcinoma | NCT02938702 | Thyroid Cancer Papillary Thyro... | 18 Years - | Seoul National University Hospital | ||
A Trial Comparing USG-HIFU vs AS in Management of Low-risk PTMC | NCT03327636 | Papillary Thyro... | Echopulse | 19 Years - 74 Years | The University of Hong Kong | |
New Treatment Modalities for Localized Prostate Cancer | NCT05523856 | Prostate Cancer | Active Surveill... Robot-Assisted ... Intensity-Modul... Real-time brach... | 50 Years - 75 Years | Fundacion IMIM | |
Vigorous or Moderate Exercise in Enhancing Active Surveillance in Patients With Localized Prostate Cancer | NCT02179762 | Recurrent Prost... Stage I Prostat... Stage IIA Prost... Stage IIB Prost... | moderate exerci... vigorous exerci... questionnaire a... laboratory biom... vigorous exerci... Exercise Logs Adherence Exercise and bo... | 18 Years - 75 Years | Case Comprehensive Cancer Center | |
Aneustat Treatment of Localized Prostate Cancer Under Active Surveillance | NCT03495479 | Prostate Cancer | OMN54 | 18 Years - 72 Years | Omnitura Therapeutics, Inc. | |
Survivorship Care Planning in Improving Quality of Life in Survivors of Ovarian Cancer | NCT02082470 | Cancer Survivor Stage IA Ovaria... Stage IB Ovaria... Stage IC Ovaria... Stage IIA Ovari... Stage IIB Ovari... Stage IIC Ovari... Stage IIIA Ovar... Stage IIIB Ovar... Stage IIIC Ovar... | follow-up care active surveill... questionnaire a... | 21 Years - | City of Hope Medical Center | |
Evaluation of a Blood Biomarker to Try and Distinguish Between the Presence or Absence of Aggressive Prostate Cancer | NCT03256630 | Prostate Cancer | - | Genomic Health®, Inc. | ||
Study In Urology Practices Looking At Impact Of OncotypeDX GPS Test On Men Choosing And Remaining On Active Surveillance | NCT03502213 | Prostate Cancer | 50 Years - | Genomic Health®, Inc. | ||
Red Yeast Rice in Subjects With Clinically Localized Prostate Cancer Undergoing Active Surveillance | NCT01687049 | Prostate Cancer | Red yeast rice | 19 Years - 90 Years | Sunnybrook Health Sciences Centre | |
Active Surveillance in Early Lung Cancer | NCT03923777 | Stage IA Non-sm... Lung Carcinoid ... | Active Surveill... | 65 Years - | University of Vermont Medical Center | |
Study of Micrometastases in Patients With Stage I or Stage II Localized Colon Cancer That Can Be Removed by Surgery | NCT01097265 | Colorectal Canc... | capecitabine oxaliplatin active surveill... laboratory biom... adjuvant therap... lymph node mapp... sentinel lymph ... | 18 Years - | National Cancer Institute (NCI) | |
Active Surveillance Exercise Clinical Trial | NCT02435472 | Localized Prost... Active Surveill... | Exercise Cardiopulmonary... | 18 Years - | University of California, San Francisco | |
DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment | NCT06075953 | Ductal Carcinom... | Tamoxifen Exemestane Letrozole Anastrazole Testosterone + ... Elacestrant Z-endoxifen | 18 Years - | QuantumLeap Healthcare Collaborative | |
STRatIfication of Vulvar SCC by HPV and p53 Status to Guide Excision | NCT06358469 | Vulvar Squamous... | Surgery Active Surveill... | 18 Years - | Canadian Cancer Trials Group | |
Surgery As Needed for Oesophageal Cancer - 2 | NCT04886635 | Cancer of Esoph... | Active surveill... | 18 Years - | Erasmus Medical Center | |
Active Surveillance for Prostate Cancer With Indolent Features | NCT00421265 | Prostate Cancer | 65 Years - 80 Years | Assaf-Harofeh Medical Center | ||
MRI in Active Surveillance of Prostate Cancer | NCT02326246 | Prostate Cancer | multi-parametic... | 18 Years - | Aarhus University Hospital Skejby | |
The Metformin Active Surveillance Trial (MAST) Study | NCT01864096 | Prostate Cancer | Metformin Placebo | 18 Years - 79 Years | University Health Network, Toronto | |
Spanish Urological Association Registry of Patients on Active Surveillance | NCT02865330 | Prostate Cancer | Registry | 18 Years - 80 Years | Fundación Instituto Valenciano de Oncología | |
TherApeutics in Early ProState Cancer (TAPS02) | NCT05191680 | Prostate Cancer | Apalutamide Ora... Placebo | 18 Years - | Cambridge University Hospitals NHS Foundation Trust | |
Surveillance of Complex Renal Cysts - The SOCRATIC Study | NCT04558593 | Complex Renal C... | Active surveill... Surgery | 18 Years - | Université de Sherbrooke | |
Seoul National University Prospectively Enrolled Registry for Prostate Cancer With Active Surveillance | NCT02971085 | Prostate Cancer | Active surveill... | 40 Years - 80 Years | Seoul National University Hospital | |
Identification and Treatment Of Micrometastatic Disease in Stage III Colon Cancer | NCT03803553 | Metastatic Colo... Stage III Colon... | FOLFIRI Protoco... ACTIVE SURVEILL... Nivolumab Proto... Encorafenib/Bin... Trastuzumab + P... | 18 Years - | Massachusetts General Hospital | |
Long-Term Prospective Registry in Prostate Cancer Patients From Diverse Urology Practice Settings Following Prolaris® Testing | NCT04404894 | Prostate Cancer | 18 Years - | Myriad Genetic Laboratories, Inc. | ||
Focal Therapy for Prostate Cancer | NCT01802307 | Prostatic Neopl... Prostate Cancer | Brachytherapy | 45 Years - | University of Maryland, Baltimore | |
MRI in Active Surveillance of Prostate Cancer | NCT02326246 | Prostate Cancer | multi-parametic... | 18 Years - | Aarhus University Hospital Skejby | |
Pioneering Advances in Care and Education (PACE) | NCT03397160 | Decision Suppor... Prostate Cancer | Decision Suppor... | 18 Years - | University of California, San Francisco | |
CAPSAICIN Trial: Assessing Capsaicin as a Chemopreventive Agent for Prostate Cancer | NCT02037464 | Prostate Cancer | Capsaicin Suppl... | 19 Years - | Sunnybrook Health Sciences Centre | |
Active Surveillance vs in Office Fulguration for Low Grade Bladder Cancer Tumors | NCT05148728 | Bladder Cancer | Endoscopic fulg... | 18 Years - | Vall Hebron Insitut Recerca | |
Vitamin D3 Supplementation for Low-Risk Prostate Cancer: A Randomized Trial | NCT01759771 | Prostate Cancer | Vitamin D3 Placebo | 19 Years - 90 Years | VA Office of Research and Development | |
STRatIfication of Vulvar SCC by HPV and p53 Status to Guide Excision | NCT06358469 | Vulvar Squamous... | Surgery Active Surveill... | 18 Years - | Canadian Cancer Trials Group | |
Outcome Assessment of an Active Surveillance Program for Low Risk Prostate Cancer: An Observational Study | NCT01376661 | Prostate Cancer | 18 Years - 90 Years | St. Joseph Hospital of Orange | ||
Trial of Curcumin to Prevent Progression of Low-risk Prostate Cancer Under Active Surveillance | NCT03769766 | Prostate Cancer | Curcumin Placebo | 40 Years - 89 Years | University of Texas Southwestern Medical Center | |
The Metformin Active Surveillance Trial (MAST) Study | NCT01864096 | Prostate Cancer | Metformin Placebo | 18 Years - 79 Years | University Health Network, Toronto | |
Active Surveillance of Papillary Thyroid Microcarcinoma | NCT02609685 | Papillary Thyro... | Active Surveill... | 18 Years - | Cedars-Sinai Medical Center | |
International REgistry of COnservative or Radical Treatment of Localized Kidney Tumors | NCT05363657 | Kidney Cancer | Partial Nephrec... Radical Nephrec... Ablation therap... Active Surveill... | 18 Years - | Azienda Ospedaliero-Universitaria Careggi | |
Spanish Urological Association Registry of Patients on Active Surveillance | NCT02865330 | Prostate Cancer | Registry | 18 Years - 80 Years | Fundación Instituto Valenciano de Oncología | |
An Organ Preservation Strategies After Chemoradiotherapy Combined With Immunotherapy for Esophageal Cancer (PALACE3). | NCT06339060 | Esophageal Canc... | Experimental: A... Active Comparat... | 18 Years - 75 Years | Ruijin Hospital | |
MRI Based Active Selection for Treatment Trial | NCT02242773 | Prostate Cancer | Multi-Parametri... MRI-Guided Biop... | 35 Years - 85 Years | University of Miami | |
Exercise During Active Surveillance for Prostate Cancer | NCT03203460 | Prostate Cancer | High-intensity ... | 18 Years - | University of Alberta | |
Optimizing Active Surveillance in Low-Risk Prostate Cancer: a Pilot Study | NCT05764005 | Prostate Cancer | web-based tool ... MUSIC website | 55 Years - | University of Michigan Rogel Cancer Center | |
MRI in Active Surveillance of Prostate Cancer | NCT02326246 | Prostate Cancer | multi-parametic... | 18 Years - | Aarhus University Hospital Skejby | |
Evaluation of an Active Surveillance Protocol for Prostate Cancer in the Brazilian Population | NCT05343936 | Prostate Cancer | Active surveill... | 18 Years - 78 Years | Hospital Moinhos de Vento | |
The Active Surveillance Study | NCT05810467 | Prostate Cancer | Active Surveill... | 18 Years - | Institute of Cancer Research, United Kingdom | |
The Active Surveillance Study | NCT05810467 | Prostate Cancer | Active Surveill... | 18 Years - | Institute of Cancer Research, United Kingdom | |
Micro-UltraSound In Cancer - Active Surveillance | NCT05558241 | Prostate Cancer | High-resolution... | 18 Years - | University of Alberta | |
Pre-Surgery If Needed for Oesophageal Cancer | NCT03937362 | Esophageal Canc... | First clinical ... Second clinical... | 20 Years - | Shanghai Chest Hospital | |
Vigorous or Moderate Exercise in Enhancing Active Surveillance in Patients With Localized Prostate Cancer | NCT02179762 | Recurrent Prost... Stage I Prostat... Stage IIA Prost... Stage IIB Prost... | moderate exerci... vigorous exerci... questionnaire a... laboratory biom... vigorous exerci... Exercise Logs Adherence Exercise and bo... | 18 Years - 75 Years | Case Comprehensive Cancer Center |